Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer
Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer
Irinotecan And Carboplatin Improve Response In NSCLC
Enzastaurin Shows Activity In Recurrent High-Grade Glioma
Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer
Gemcitabine Improves DFS In Resected Pancreatic Cancer
Rosenberg: Immunotherapy May Have Broad Potential
NCI-Approved Clinical Trials
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
